Abstract:Background Epithelial‐mesenchymal transition (EMT) is central to HCC metastasis, in which RNA‐binding proteins (RBPs) play a key role. Methods To explore the role of RBPs in metastasis of hepatocellular carcinoma (HCC), whole transcriptome sequencing was conducted to identify differential RBPs between HCC with metastasis and HCC without metastasis. The influence of RBPs on metastasis of HCC was verified by in vitro and in vivo experiments. The interaction of RBPs with non‐coding RNAs was evaluated by RNA immunoprecipitation and pull‐down assays. RNA sequencing, whole‐genome sequencing, and alternative splicing analysis were further performed to clarify post‐transcriptional regulation mechanisms. Results Whole transcriptome sequencing results showed that expression of thioredoxin (Trx) was significantly upregulated in HCC patients with metastasis. Trx was also found to be associated with poor prognosis in HCC patients. Overexpression of Trx could promote migration and invasion of HCC cells in vitro and increase the rate of lung metastasis of HCC cells in vivo. Moreover, binding assays showed that Trx could bind to LINC00152. As a result, LINC00152 was verified to determine the pro‐metastasis function of Trx by knockdown assay. Furthermore, we revealed that Trx could regulate metastasis‐associated alternative splicing program. Specifically, angiopoietin 1 (ANGPT1) was the splicing target; the splicing isoform switching of ANGPT1 could activate the PI3K–Akt pathway, upregulate EMT‐associated proteins, and promote migration and invasion of HCC cells. Conclusions We found that Trx could interact with LINC00152 and promote HCC metastasis via regulating alternative splicing, indicating that Trx may serve as a novel therapeutic target for HCC treatment.

Skipping of Exon 10 in Axl Pre-Mrna Regulated by PTBP1 Mediates Invasion and Metastasis Process of Liver Cancer Cells

The Truncated AXIN1 Isoform Promotes Hepatocellular Carcinoma Metastasis Through SRSF9-mediated Exon 9 Skipping

SRSF10 Facilitates HCC Growth and Metastasis by Suppressing CD8+T Cell Infiltration and Targeting SRSF10 Enhances Anti-Pd-l1 Therapy

PPM1G‐mediated TBL1X mRNA splicing promotes cell migration in hepatocellular carcinoma

The Role of XBP1s in the Metastasis and Prognosis of Hepatocellular Carcinoma

PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2

DDX17‐regulated alternative splicing that produced an oncogenic isoform of PXN‐AS1 to promote HCC metastasis

Axl Expression Stratifies Patients With Poor Prognosis After Hepatectomy For Hepatocellular Carcinoma

RNA‐binding protein Trx regulates alternative splicing and promotes metastasis of HCC via interacting with LINC00152

Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma

PTBP1 Enhances Exon11a Skipping in Mena Pre-Mrna to Promote Migration and Invasion in Lung Carcinoma Cells.

TATA-box-binding Protein Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-Mesenchymal Transition.

The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma

PCBP1 regulates the transcription and alternative splicing of metastasis‐related genes and pathways in hepatocellular carcinoma

AXL Overexpression in Tumor-Derived Endothelial Cells Promotes Vessel Metastasis in Patients With Hepatocellular Carcinoma

The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing

Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression

SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma

USP39 Promotes Hepatocellular Carcinogenesis Through Regulating Alternative Splicing in Cooperation with SRSF6/HNRNPC

Identification of Prognostic and Metastasis-Related Alternative Splicing Signatures in Hepatocellular Carcinoma.

The Alternative Splicing of Intersectin 1 Regulated by PTBP1 Promotes Human Glioma Progression.